Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • dinepat203 dinepat203 Nov 29, 2012 2:40 PM Flag

    DOUKNOW ? ISIS -FDA approved Drug Vitravene Rx FOR CMV-AIDS medication.

    ISIS -Vitravene, a drug to treat an AIDS-related infection of the retina called cytomegalovirus, or CMV. The FDA approved Vitravene in 1998, on the market just as powerful AIDS medications changed the course of the disease, as AIDS patients can develop CMV

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Nov 29,2012- CIBA Vision Corporation, the eye care unit of Novartis AG, today announced the launch of Vitravene (fomivirsen sodium intravitreal injectable), for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. The announcement was made at the American Academy of Ophthalmology Annual Meeting in New Orleans. Vitravene is the first in a class of novel therapeutics based on an antisense mechanism to be approved for marketing in the U.S. Vitravene is indicated for the local treatment of CMV retinitis in patients with AIDS who are intolerant of or have a contraindication to other treatments for CMV retinitis or who were insufficiently responsive to previous treatments for CMV retinitis. A Marketing Authorization Application (MAA) submitted by CIBA Vision is currently under review with the European Agency for the Evaluation of Medicinal Products (EMEA) for the marketing of Vitravene in Europe. CIBA Vision's partner in the discovery and development of Vitravene is Isis Pharmaceuticals (Nasdaq: ISIP), Carlsbad, Calif.

 
ISIS
57.560.00(0.00%)Dec 21 4:00 PMEST